申请人:CHEMOCENTRYX, INC.
公开号:US10407417B2
公开(公告)日:2019-09-10
Aniline compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.
所提供的苯胺化合物与 CCR(4) 结合,可用于治疗过敏性疾病、自身免疫性疾病、移植物排斥和癌症等疾病。